Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Cell Analysis Products
  4. Microspheres
  5. 501125065

Invitrogen™ MagniSort™ Human CD8 Positive Selection Kit

Catalog No. 501125065
Encompass_Preferred
Click to view available options
Quantity:
200 tests
Contains Sodium azide
Contains Sodium azide

Description

Includes

  • MagniSort Anti-Human CD8 Biotin : 200 tests, 20μL/test
  • MagniSort Positive Selection Beads A

Designed for the magnetic separation of CD8+ cells by positive selection. It has been optimized for the isolation of CD8+ cells from human peripheral blood monocuclear cells, utilizing a biotinylated Anti-Human CD8 antibody and streptavidin-coated magnetic beads.

  • CD8+ cells are bound by antibody and then magnetic beads
  • When placed in a magnetic field, the undesired cells can be separated from CD8+ cells by decanting
  • After positive selection, the purity of selected cells can be verified by staining with Anti-Human CD8, clones RPA-T8 or SK1
TRUSTED_SUSTAINABILITY

Specifications

Cell Type CD8+
Product Type Positive Selection Kit
No. of Tests 200 tests
Quantity 200 tests
Target Species Human

For Research Use Only. Not for use in diagnostic procedures.

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.